Phospholine iodine (217MI) and demecarium bromide (BC48) in the management of glaucoma.
D002800:Cholinesterase Inhibitors; D003650:Decamethonium Compounds / Q000628:therapy*; D005901:Glaucoma / Q000628:therapy*; D007455:Iodine; D007783:Lactones; D009943:Organophosphorus Compounds; D010277:Parasympathomimetics / Q000628:therapy*; D000644:Quaternary Ammonium Compounds
D002800:Cholinesterase Inhibitors; D003650:Decamethonium Compounds; D007783:Lactones; D009943:Organophosphorus Compounds; D010277:Parasympathomimetics; D000644:Quaternary Ammonium Compounds; C061212:phospholine; D007455:Iodine; C100193:demecarium
CHOLINESTERASE/antagonists; DECAMETHONIUM COMPOUNDS/therapy; GLAUCOMA/therapy; PARASYMPATHOMIMETICS/therapy